Correlation Among [18F]Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography, Cancer Antigen 27.29, and Circulating Tumor Cell Testing in Metastatic Breast CancerAyman Saad, Jame Abraham, Abraham S. Kanate et al.|Clinical Breast Cancer|2008Cited by 17
Higher infused CD34+ cell dose and overall survival in patients undergoing in vivo T-cell depleted, but not t-cell repleted, allogeneic peripheral blood hematopoietic cell transplantationAbraham S. Kanate, Mehdi Hamadani, Scot C. Remick et al.|Hematology/Oncology and Stem Cell Therapy|2011Cited by 10
Correlation among [18-F] FDG-PET/CT, tumor marker CA 27.29, and circulating tumor cells in metastatic breast cancerAyman Saad, Jame Abraham, Somi Rikhye et al.|Journal of Clinical Oncology|2007Cited by 2
Balancing Acute Graft Versus Host Disease (aGVHD) and Survival after Peripheral Allogeneic Stem Cell Transplantation (SCT) in Hematological Malignancies: A Potential for Graft Engineering.Ayman Saad, Michael Craig, Mohammed Almubarak et al.|Blood|2007Cited by 1
In Vivo T-Cell Depletion (TCD) Does Not Improve Rates of Graft-Versus-Host Disease (GVHD) and Transplantation Outcomes in Patients Undergoing Peripheral Blood Allogeneic Hematopoietic Cell Transplant (AHCT)Abraham S. Kanate, Mehdi Hamadani, Samira Osman et al.|Transplantation and Cellular Therapy|2011Cited by 0